| Literature DB >> 31179415 |
Kristiyana Kaneva1, Kee Kiat Yeo1, Debra Hawes2, Jianling Ji2, Jaclyn A Biegel2, Marvin D Nelson3, Stefan Bluml3, Mark D Krieger4, Anat Erdreich-Epstein1,2,5,6.
Abstract
Entities:
Keywords: BRAF V600E; CDKN2A; brain tumors; gliofibroma; pediatric; targeted therapy; trametinib; vemurafenib
Year: 2019 PMID: 31179415 PMCID: PMC6555144 DOI: 10.1200/PO.18.00138
Source DB: PubMed Journal: JCO Precis Oncol ISSN: 2473-4284